These remaining cisplatin-resistant bladder cancer cells include the existence of CSC-like cells that display higher levels of Bmi1 and Nanog expression, EMT characteristics, CSC marker expression, and sphere-forming capacity, conferring them a role in progression and drug resistance of bladder cancer [80]. Here, NANOG is linked to urinary bladder cancer.